| ［1］ |
Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus⁃like DNA sequences in AIDS⁃associated Kaposi′s sarcoma［J］. Science, 1994,266（5192）:1865⁃1869. doi: 10.1126/ science.7997879.
|
| ［2］ |
Cesarman E, Chadburn A, Rubinstein PG. KSHV/HHV8⁃mediated hematologic diseases［J］. Blood, 2022,139（7）:1013⁃1025. doi: 10.1182/blood.2020005470.
|
| ［3］ |
Bennett SJ, Yalcin D, Privatt SR, et al. Antibody epitope profiling of the KSHV LANA protein using VirScan［J/OL］. PLoS Pathog, 2022,18（12）:e1011033. doi: 10.1371/journal.ppat.1011033.
|
| ［4］ |
Luo T, Pan Y, Liu Y, et al. LANA regulates miR⁃155/GATA3 signaling axis by enhancing c⁃Jun/c⁃Fos interaction to promote the proliferation and migration of KSHV⁃infected cells［J］. J Med Virol, 2023,95（1）:e28255. doi: 10.1002/jmv.28255.
|
| ［5］ |
Tan M, Li S, Juillard F, et al. MLL1 is regulated by KSHV LANA and is important for virus latency［J］. Nucleic Acids Res, 2021,49（22）:12895⁃12911. doi: 10.1093/nar/gkab1094.
|
| ［6］ |
Combs LR, Spires LM, Alonso JD, et al. KSHV RTA induces degradation of the host transcription repressor ID2 to promote the viral lytic cycle［J］. J Virol, 2022,96（12）:e0010122. doi: 10.1128/jvi.00101⁃22.
|
| ［7］ |
Di C, Zheng G, Zhang Y, et al. RTA and LANA competitively regulate let⁃7a/RBPJ signal to control KSHV replication［J］. Front Microbiol, 2021,12:804215. doi: 10.3389/fmicb.2021.80 4215.
|
| ［8］ |
Mamimandjiami AI, Mouinga⁃Ondémé A, Ramassamy JL, et al. Epidemiology and genetic variability of HHV⁃8/KSHV among rural populations and Kaposi′s sarcoma patients in Gabon, central Africa. Review of the geographical distribution of HHV⁃8 K1 genotypes in Africa［J］. Viruses, 2021,13（2）:175. doi: 10. 3390/v13020175.
|
| ［9］ |
Choi UY, Lee JJ, Park A, et al. Oncogenic human herpesvirus hijacks proline metabolism for tumorigenesis［J］. Proc Natl Acad Sci USA, 2020,117（14）:8083⁃8093. doi: 10.1073/pnas.191860 7117.
|
| ［10］ |
Tamanaha⁃Nakasone A, Uehara K, Tanabe Y, et al. K1 gene transformation activities in AIDS⁃related and classic type Kaposi′s sarcoma: correlation with clinical presentation［J］. Sci Rep, 2019,9（1）:6416. doi: 10.1038/s41598⁃019⁃42763⁃0.
|
| ［11］ |
Samarina N, Ssebyatika G, Tikla T, et al. Recruitment of phospholipase Cγ1 to the non⁃structural membrane protein pK15 of Kaposi sarcoma⁃associated herpesvirus promotes its Src⁃dependent phosphorylation［J/OL］. PLoS Pathog, 2021,17（6）:e1009635. doi: 10.1371/journal.ppat.1009635.
|
| ［12］ |
Abere B, Mamo TM, Hartmann S, et al. The Kaposi′s sarcoma⁃associated herpesvirus（KSHV） non⁃structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target［J/OL］. PLoS Pathog, 2017,13（9）:e1006639. doi: 10.1371/journal.ppat.1006639.
|
| ［13］ |
吴秀娟, 普雄明, 吴卫东. 人类疱疹病毒8型ORF26基因亚型与Kaposi肉瘤的相关性研究［J］. 中华皮肤科杂志, 2008,41（11）:732⁃735. doi: 10.7666/d.Y1375481.
|
| ［14］ |
Wang Y, Nie C, Zang T, et al. Predicting circRNA⁃disease associations based on circRNA expression similarity and functional similarity［J］. Front Genet, 2019,10:832. doi: 10. 3389/fgene.2019.00832.
|
| ［15］ |
Abere B, Li J, Zhou H, et al. Kaposi′s sarcoma⁃associated herpesvirus⁃encoded circRNAs are expressed in infected tumor tissues and are incorporated into virions［J］. mBio, 2020,11（1）:e03027⁃19. doi: 10.1128/mBio.03027⁃19.
|
| ［16］ |
Wen Z, Li W, Fang Y, et al. Prevalence and risk factors of Kaposi′s sarcoma⁃associated herpesvirus infection among Han and Uygur populations in Xinjiang, China［J］. Can J Infect Dis Med Microbiol, 2021,2021:2555865. doi: 10.1155/2021/2555865.
|
| ［17］ |
García⁃Cisneros S, Sánchez⁃Alemán MÁ, Conde⁃Glez CJ, et al. Performance of ELISA and Western blot to detect antibodies against HSV⁃2 using dried blood spots［J］. J Infect Public Health, 2019,12（2）:224⁃228. doi: 10.1016/j.jiph.2018.10.007.
|
| ［18］ |
Engels EA, Whitby D, Goebel PB, et al. Identifying human herpesvirus 8 infection: performance characteristics of serologic assays［J］. J Acquir Immune Defic Syndr, 2000,23（4）:346⁃354. doi: 10.1097/00126334⁃200004010⁃00011.
|
| ［19］ |
Corgiat M, Calvez V, Marcelin AG, et al. Methods comparison for molecular diagnosis of human herpesvirus 8 infections［J］. J Clin Virol, 2020,126:104308. doi: 10.1016/j.jcv.2020.104308.
|
| ［20］ |
Biatougou NM, Ouedraogo MS, Soubeiga ST, et al. Molecular epidemiology of human herpes virus type 8 among patients with compromised immune system in Ouagadougou, Burkina Faso［J］. HIV AIDS（Auckl）, 2022,14:311⁃317. doi: 10.2147/HIV.S353166.
|
| ［21］ |
Lopes AO, Lima L, Tozetto⁃Mendoza TR, et al. Low prevalence of human gammaherpesvirus 8（HHV⁃8） infection among HIV⁃infected pregnant women in Rio De Janeiro, Brazil［J］. J Matern Fetal Neonatal Med, 2021,34（20）:3458⁃3461. doi: 10.1080/14767058.2019.1685967.
|
| ［22］ |
Kenmoe S, Vernet MA, Penlap Beng V, et al. Phylogenetic variability of human metapneumovirus in patients with acute respiratory infections in Cameroon, 2011⁃2014［J］. J Infect Public Health, 2020,13（4）:606⁃612. doi: 10.1016/j.jiph.2019. 08.018.
|
| ［23］ |
Gomez⁃Martinez J, Foulongne V, Laureillard D, et al. Near⁃point⁃of⁃care assay with a visual readout for detection of HIV⁃1 drug resistance mutations: a proof⁃of⁃concept study［J］. Talanta, 2021,231:122378. doi: 10.1016/j.talanta.2021.122378.
|
| ［24］ |
Kury C, Guimaraes GR, Leandro CG, et al. Associations of human papillomavirus（HPV） genotypes and related risk factors in a cohort of women living with HIV in a Brazilian countryside city［J］. J Med Virol, 2022,94（6）:2802⁃2810. doi: 10.1002/jmv.27582.
|
| ［25］ |
Mou X, Sheng D, Chen Z, et al. In⁃situ mutation detection by magnetic deads⁃probe based on single base extension and its application in genotyping of hepatitis B virus pre⁃C region 1896nt locus single nucleotide polymorphisms［J］. J Biomed Nanotechnol, 2019,15（12）:2393⁃2400. doi: 10.1166/jbn.2019. 2862.
|
| ［26］ |
Hulaniuk ML, Corach D, Trinks J, et al. A simple and rapid approach for human herpesvirus type 8 subtype characterization using single base extension［J］. Lett Appl Microbiol, 2021,73（3）:308⁃317. doi: 10.1111/lam.13515.
|
| ［27］ |
Hu T, Chitnis N, Monos D, et al. Next⁃generation sequencing technologies: an overview［J］. Hum Immunol, 2021,82（11）:801⁃811. doi: 10.1016/j.humimm.2021.02.012.
|
| ［28］ |
Pai JA, Satpathy AT. High⁃throughput and single⁃cell T cell receptor sequencing technologies［J］. Nat Methods, 2021,18（8）:881⁃892. doi: 10.1038/s41592⁃021⁃01201⁃8.
|
| ［29］ |
Zhou K, Xu J, Shang Z, et al. Case report: metagenomic next⁃generation sequencing can contribute to the diagnosis and treatment of disseminated visceral Kaposi sarcoma following allogeneic haematopoietic stem cell transplantation［J］. Front Oncol, 2022,12:848976. doi: 10.3389/fonc.2022.848976.
|
| ［30］ |
Nalwoga A, Webb EL, Muserere C, et al. Variation in KSHV prevalence between geographically proximate locations in Uganda［J］. Infect Agent Cancer, 2020,15:49. doi: 10.1186/s13027⁃020⁃00313⁃8.
|
| ［31］ |
Lee YM, Hung PS, Lin CW. Seroepidemiology and phylogenetic analysis of human herpesvirus type 8 in injection drug users and men who have sex with men in northern Taiwan［J］. J Int Med Res, 2020,48（1）:3000605 18764747. doi: 10.1177/0300060518 764747.
|
| ［32］ |
Jary A, Leducq V, Desire N, et al. New Kaposi′s sarcoma⁃associated herpesvirus variant in men who have sex with men associated with severe pathologies［J］. J Infect Dis, 2020,222（8）:1320⁃1328. doi: 10.1093/infdis/jiaa180.
|
| ［33］ |
Piselli P, Taborelli M, Cimaglia C, et al. Decreased incidence of Kaposi sarcoma after kidney transplant in Italy and role of mTOR⁃inhibitors: 1997⁃2016［J］. Int J Cancer, 2019,145（2）:597⁃598. doi: 10.1002/ijc.32098.
|
| ［34］ |
Marashi SM, Mostafa A, Shoja Z, et al. Human herpesvirus 8 DNA detection and variant analysis in patients with multiple sclerosis［J］. Virusdisease, 2018,29（4）:540⁃543. doi: 10.1007/s13337⁃018⁃0481⁃1.
|
| ［35］ |
Gómez I, Pérez⁃Vázquez MD, Tarragó D. Molecular epidemiology of Kaposi sarcoma virus in Spain［J/OL］. PLoS One, 2022,17（10）:e0274058. doi: 10.1371/journal.pone.0274058.
|
